ACHC250117C60000
- 0.11
- 0.000.00%
Acadia Healthcare Newsroom
Acadia Healthcare Co Analyst Ratings
RBC Capital Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $64
RBC Capital Keeps Their Buy Rating on Acadia Healthcare (ACHC)
Acadia Healthcare Is Maintained at Buy by TD Cowen
Acadia Healthcare Co Analyst Ratings
KeyBanc Upgrades Acadia Healthcare to Overweight From Sector Weight, Sets $70 Price Target
TD Cowen Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Cuts Target Price to $66
Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Acadia Healthcare (ACHC) and Genmab (GMAB)
Deutsche Bank Upgrades Acadia Healthcare(ACHC.US) to Buy Rating, Raises Target Price to $75
Deutsche Bank Upgrades Acadia Healthcare to Buy From Hold, Adjusts Price Target to $75 From $45
Cantor Fitzgerald Maintains Acadia Healthcare(ACHC.US) With Hold Rating, Cuts Target Price to $52
Acadia Healthcare Co Analyst Ratings
Cantor Fitzgerald Maintains Acadia Healthcare(ACHC.US) With Hold Rating, Cuts Target Price to $52
TD Cowen Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Cuts Target Price to $70
Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA), Acadia Healthcare (ACHC) and Bicara Therapeutics Inc. (BCAX)
Barclays Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Maintains Target Price $43
Mizuho Securities Maintains Acadia Healthcare(ACHC.US) With Hold Rating, Announces Target Price $48
Acadia Healthcare Is Maintained at Overweight by Barclays
Barclays Maintains Acadia Healthcare(ACHC.US) With Buy Rating, Cuts Target Price to $43
Barclays Reaffirms Their Buy Rating on Acadia Healthcare (ACHC)